Cargando…

Improving CHA(2)DS(2)-VASc stratification of non-fatal stroke and mortality risk using the Intermountain Mortality Risk Score among patients with atrial fibrillation

BACKGROUND: Oral anticoagulation (OAC) therapy guidelines recommend using CHA(2)DS(2)-VASc to determine OAC need in atrial fibrillation (AF). A usable tool, CHA(2)DS(2)-VASc is challenged by its predictive ability. Applying components of the complete blood count and basic metabolic profile, the Inte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Graves, Kevin G, May, Heidi T, Knowlton, Kirk U, Muhlestein, Joseph B, Jacobs, Victoria, Lappé, Donald L, Anderson, Jeffrey L, Horne, Benjamin D, Bunch, Thomas Jared
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Arrhythmias and Sudden Death
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269639/ https://www.ncbi.nlm.nih.gov/pubmed/30564375 http://dx.doi.org/10.1136/openhrt-2018-000907

Ejemplares similares

Impact of timing of atrial fibrillation, CHA(2)DS(2)-VASc score and cancer therapeutics on mortality in oncology patients
por: Hussain, Muzna, et al.
Publicado: (2020)

CHA(2)DS(2)-VASc score, left atrial size and atrial fibrillation as stroke risk factors in the Tromsø Study
por: Tiwari, Sweta, et al.
Publicado: (2016)

Age-specific atrial fibrillation incidence, attributable risk factors and risk of stroke and mortality: results from the MORGAM Consortium
por: Morseth, Bente, et al.
Publicado: (2021)

Proposed A(2)C(2)S(2)-VASc score for predicting atrial fibrillation development in patients with atrial flutter
por: Chen, Yung-Lung, et al.
Publicado: (2021)

Mortality and oral anticoagulants in the Food and Drug Administration Adverse Event Reporting System
por: Serebruany, Victor, et al.
Publicado: (2017)

Incidence, treatment and mortality of new-onset atrial fibrillation patients at the intensive care unit
por: Jacobs, Maartje S, et al.
Publicado: (2020)

Mortality and ventricular arrhythmia after acute myocarditis: a nationwide registry-based follow-up study
por: Kragholm, Kristian Hay, et al.
Publicado: (2021)

Association of QT interval with mortality by kidney function: results from the National Health and Nutrition Examination Survey (NHANES)
por: Malik, Rehan, et al.
Publicado: (2017)

Predictors of risk for sudden death in childhood hypertrophic cardiomyopathy: the importance of the ECG risk score
por: Östman-Smith, Ingegerd, et al.
Publicado: (2017)

Estimated incidence and risk factors of sudden unexpected death
por: Lewis, Mary Elizabeth, et al.
Publicado: (2016)

Familial risk of atrioventricular block in first-degree relatives
por: Dyssekilde, Johnni Resdal, et al.
Publicado: (2022)

Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke
por: García Rodríguez, Luis Alberto, et al.
Publicado: (2021)

Long-term risk of atrial fibrillation after the death of a partner
por: Graff, Simon, et al.
Publicado: (2016)

Modifiable risk factors predict incident atrial fibrillation and heart failure
por: Wong, Jorge A, et al.
Publicado: (2020)

Cardiovascular and renal multimorbidity increase risk of atrial fibrillation in the PREVEND cohort
por: Van Deutekom, Colinda, et al.
Publicado: (2023)

Cost-effectiveness of an insertable cardiac monitor in a high-risk population in the UK
por: Rinciog, Claudia I, et al.
Publicado: (2019)

Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac sarcoidosis
por: Yoshitomi, Ryosuke, et al.
Publicado: (2022)

Risk of out-of-hospital cardiac arrest in patients with rheumatoid arthritis: a nationwide study
por: Hegazy, Hatem, et al.
Publicado: (2022)

External validation and updating of prediction models of bleeding risk in patients with cancer receiving anticoagulants
por: Trinks-Roerdink, EM, et al.
Publicado: (2023)

High prevalence of modifiable stroke risk factors identified in a pharmacy-based screening programme
por: Sandhu, Roopinder K, et al.
Publicado: (2016)

Rates and risk of arrhythmias in cancer survivors with chemotherapy-induced cardiomyopathy compared with patients with other cardiomyopathies
por: Fradley, Michael G, et al.
Publicado: (2017)

Improving the quality of care for patients with or at risk of atrial fibrillation: an improvement initiative in UK general practices
por: Adeleke, Yewande, et al.
Publicado: (2019)

Arrhythmia prevalence and sudden death risk in adults with the m.3243A>G mitochondrial disorder
por: Bourke, John P, et al.
Publicado: (2022)

Prediction of short-term atrial fibrillation risk using primary care electronic health records
por: Nadarajah, Ramesh, et al.
Publicado: (2023)

Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care
por: Allan, Victoria, et al.
Publicado: (2017)

Risk and protective factors for atrial fibrillation after cardiac surgery and valvular interventions: an umbrella review of meta-analyses
por: Charitakis, Emmanouil, et al.
Publicado: (2022)

Risk of out-of-hospital cardiac arrest in patients with sarcoidosis: a Danish nationwide nested case–control study
por: Eroglu, Talip E, et al.
Publicado: (2023)

Systematic review of the incidence and clinical risk predictors of atrial fibrillation and permanent pacemaker implantation for bradycardia in Fabry disease
por: Vijapurapu, Ravi, et al.
Publicado: (2023)

Long-term stress conditions and out-of-hospital cardiac arrest risk: a nested case–control study
por: Eroglu, Talip E, et al.
Publicado: (2023)

Obesity is associated with impaired long-term success of pulmonary vein isolation: a plea for risk factor management before ablation
por: De Maat, Gijs E, et al.
Publicado: (2018)

Distinct risk factors of atrial fibrillation in patients with and without coronary artery disease: a cross-sectional analysis of the BOREAS-CAG Registry data
por: Murakami, Naoto, et al.
Publicado: (2017)

Impact of a single non-sex-related stroke risk factor on atrial fibrillation and oral anticoagulant outcomes: a systematic review and meta-analysis
por: Grymonprez, Maxim, et al.
Publicado: (2020)

Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials
por: Martin, Ruairidh I R, et al.
Publicado: (2014)

Genetic, clinical and pharmacological determinants of out-of-hospital cardiac arrest: rationale and outline of the AmsteRdam Resuscitation Studies (ARREST) registry
por: Blom, M T, et al.
Publicado: (2014)

Sudden Unexpected Death in North Carolina (SUDDEN): methodology review and screening results
por: Nanavati, Parin P, et al.
Publicado: (2014)

A pilot study of angiotensin converting enzyme (ACE) genotype and return of spontaneous circulation following out-of-hospital cardiac arrest
por: Lindner, Thomas W, et al.
Publicado: (2014)

Feasibility and outcomes of ajmaline provocation testing for Brugada syndrome in children in a specialist paediatric inherited cardiovascular diseases centre
por: McMillan, Merlin Ranald, et al.
Publicado: (2014)

Myocardial scar burden predicts survival benefit with implantable cardioverter defibrillator implantation in patients with severe ischaemic cardiomyopathy: influence of gender
por: Kwon, Deborah H, et al.
Publicado: (2014)

Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis
por: Providência, Rui, et al.
Publicado: (2014)

Heart rate is associated with progression of atrial fibrillation, independent of rhythm
por: Holmqvist, Fredrik, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j61pic14fip22ctqt8v8euv459